Dorothy Clarke - Jan 1, 2024 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Role
General Counsel, Director
Signature
/s/ Dorothy Clarke
Stock symbol
ERNA
Transactions as of
Jan 1, 2024
Transactions value $
$0
Form type
4
Date filed
1/3/2024, 05:01 PM
Previous filing
Nov 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Stock Option (right to buy) Award $0 +169K $0.00 169K Jan 1, 2024 Common Stock, par value $0.005 per share 169K $1.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to continued service, 25% of the shares underlying the stock option will vest on the nine-month anniversary of the grant date, and the remaining shares underlying the stock option will vest in 39 substantially equal monthly installments thereafter.